PRA International, Inc.
Member Sector: Clinical Research
PRA is a Clinical Research Organization known worldwide for its therapeutic excellence in Oncology, CNS, Cardiology and Respiratory Disease. The staff of more than 2,700 employees is based throughout the world to support operations on six continents. Operating from a common, global technology platform that maximizes resource efficiency and client access to data, PRA can take a molecule full cycle, from first-in-human studies through approval and ongoing safety monitoring and post-marketing studies. PRA International is a full-service CRO that offers a broad array of services encompassing the entire spectrum of clinical development, from filing Investigational New Drug (IND) and similar applications to Product Registration, post-marketing services, Regulatory Affairs and safety studies. PRA’s core services are:
Early Development Services Pioneers in the use of microdosing, PRA specializes in the more complex, first-in-human studies and studies with delicate pharmacokinetic or pharmacodynamic objectives. Our GLP-compliant Bioanalytical Laboratory in the Netherlands has hosted more than 2,400 studies in the past 22 years and used more than 250 validated biomarker methods.
Product Registration Services Product Registration represents the core of PRA’s business focus. The company’s global footprint allows it to conduct Phase IIb-III studies in more than 60 countries in North America, South America, Europe, Asia, Africa and Australia and facilitates access to specific, program-driven patient populations. Scientific & Medical Affairs Scientific & Medical Affairs is the center of PRA’s therapeutic expertise and consulting services. PRA can advance a client’s clinical development program throughout the development lifecycle, providing services for Feasibility, Safety and Risk Management, Regulatory Affairs and Phase IV and post-marketing studies. |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |